PathoQuest now offering GMP validated NGS Viral Vector Identity test at U.S. site

We now offer our GMP validated Viral Vector Identity test at our Wayne, PA site, as well as at our site in Paris, France. Our NGS-based identity test is performed on a short read sequencing platform enabling excellent detection capabilities for very low occurrence variance detection.

The workflow for our assay, from sample preparation, through sequencing and bioinformatics, is fully validated to GMP. The output is a GMP Certificate of Analysis which is supported by the consensus sequence and any variant sequences >5% detected.

CLICK HERE to learn more about our viral vector test offerings